Literature DB >> 1600629

Infraorbital nerve blockade from birth does not disrupt central trigeminal pattern formation in the rat.

T A Henderson1, T A Woolsey, M F Jacquin.   

Abstract

We tested the hypothesis that patterned primary afferent impulse activity during early postnatal periods is necessary for central trigeminal pattern formation. Newborn rats had their whiskers trimmed daily and new slices of slow release polymer containing the sodium channel blocker, tetrodotoxin, were placed under the infraorbital nerve every 8 h for up to 9 days. Electrophysiological recordings indicated that trigeminal ganglion cells were unresponsive to peripheral stimuli and chronically silenced. Trigeminal ganglion cell numbers were unaffected by nerve blockade. Cytochrome oxidase staining patterns in the trigeminal brainstem complex, thalamus, and barrel cortex were normal on postnatal day 1, 3, 5, 7, or 9 (n = 4 each). Whisker-related patches were of normal sizes and staining densities. Similar negative results were obtained in 9 rats in which whiskers were trimmed daily and the long-acting local anesthetic bupivacaine was injected into the whisker pad at 2.5- to 4-h intervals from birth to sacrifice on postnatal day 5-9. Cytochrome oxidase staining patterns and patch properties again did not differ from normal. Thus, trigeminal pattern formation occurs even when the entire infraorbital nerve is silenced from birth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600629     DOI: 10.1016/0165-3806(92)90152-m

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  23 in total

1.  Vibrissae-evoked behavior and conditioning before functional ontogeny of the somatosensory vibrissae cortex.

Authors:  M S Landers; R M Sullivan
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

Review 2.  Neural activity: sculptor of 'barrels' in the neocortex.

Authors:  R S Erzurumlu; P C Kind
Journal:  Trends Neurosci       Date:  2001-10       Impact factor: 13.837

3.  Characterizing the functional significance of the neonatal rat vibrissae prior to the onset of whisking.

Authors:  Regina M Sullivan; Margo S Landers; Jennifer Flemming; Cara Vaught; Theresa A Young; H Jonathan Polan
Journal:  Somatosens Mot Res       Date:  2003       Impact factor: 1.111

Review 4.  Development and critical period plasticity of the barrel cortex.

Authors:  Reha S Erzurumlu; Patricia Gaspar
Journal:  Eur J Neurosci       Date:  2012-05       Impact factor: 3.386

5.  Age-related decrease of the chorda tympani nerve terminal field in the nucleus of the solitary tract is prevented by dietary sodium restriction during development.

Authors:  S I Sollars; B R Walker; A K Thaw; D L Hill
Journal:  Neuroscience       Date:  2005-12-09       Impact factor: 3.590

Review 6.  Molecular determinants of the face map development in the trigeminal brainstem.

Authors:  Reha S Erzurumlu; Zhou-Feng Chen; Mark F Jacquin
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-02

7.  Gustatory terminal field organization and developmental plasticity in the nucleus of the solitary tract revealed through triple-fluorescence labeling.

Authors:  Olivia L May; David L Hill
Journal:  J Comp Neurol       Date:  2006-08-01       Impact factor: 3.215

8.  Conversion of functional synapses into silent synapses in the trigeminal brainstem after neonatal peripheral nerve transection.

Authors:  Fu-Sun Lo; Reha S Erzurumlu
Journal:  J Neurosci       Date:  2007-05-02       Impact factor: 6.167

9.  Rapid alteration of thalamocortical axon morphology follows peripheral damage in the neonatal rat.

Authors:  S M Catalano; R T Robertson; H P Killackey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Glutamate receptor blockade at cortical synapses disrupts development of thalamocortical and columnar organization in somatosensory cortex.

Authors:  K Fox; B L Schlaggar; S Glazewski; D D O'Leary
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.